-
1
-
-
15944424472
-
Adverse effects
-
Hooper D, Rubinstein E, editors American Society for Microbiology, Washington;
-
Lode H, Rubinstein E. Adverse effects. In: Hooper D, Rubinstein E, editors. Quinolone antimicrobial agents. 3rd edition. American Society for Microbiology, Washington; 2003. p. 407-19
-
(2003)
Quinolone Antimicrobial Agents. 3rd Edition
, pp. 407-419
-
-
Lode, H.1
Rubinstein, E.2
-
3
-
-
65949098180
-
Safety profile of the respiratory fluoroquinolone moxifloxacin: Comparison with other fluoroquinolones and other antibacterial classes
-
van Bambeke F, Tulkens PM. Safety profile of the respiratory fluoroquinolone moxifloxacin: comparison with other fluoroquinolones and other antibacterial classes. Drug Saf 2009;32:359-578
-
(2009)
Drug Saf
, vol.32
, pp. 359-578
-
-
Van Bambeke, F.1
Tulkens, P.M.2
-
4
-
-
77951107090
-
Safety profile of the fluoroquinolones: Focus on levofloxacin
-
Liu HH. Safety profile of the fluoroquinolones: focus on levofloxacin. Drug Saf 2010;33:353-69
-
(2010)
Drug Saf
, vol.33
, pp. 353-369
-
-
Liu, H.H.1
-
5
-
-
0001424862
-
Safety overview. Toxicity adverse effects and drug interactions
-
Andriole V editor Academic Press London
-
Stahlmann R, Lode H. Safety overview. Toxicity, adverse effects, and drug interactions. In: Andriole V, editor. The Quinolones. 3rd edition. Academic Press, London; 2000. p. 397-453
-
(2000)
The Quinolones. 3rd Edition
, pp. 397-453
-
-
Stahlmann, R.1
Lode, H.2
-
6
-
-
0037186895
-
Clinical toxicological aspects of fluoroquinolones
-
DOI 10.1016/S0378-4274(01)00509-4, PII S0378427401005094
-
Stahlmann R. Clinical toxicological aspects of fluoroquinolones. Toxicol Lett 2002;127:269-77 (Pubitemid 34615518)
-
(2002)
Toxicology Letters
, vol.127
, Issue.1-3
, pp. 269-277
-
-
Stahlmann, R.1
-
7
-
-
84867330853
-
Improving known classes of antibiotics: An optimistic approach for the future
-
Bush K. Improving known classes of antibiotics: an optimistic approach for the future. Curr Opin Pharmacol 2012;12:527-34
-
(2012)
Curr Opin Pharmacol
, vol.12
, pp. 527-534
-
-
Bush, K.1
-
8
-
-
45249087419
-
Fluoroquinolone resistance in Clostridium difficile isolates from a prospective study of C. difficile infections in Europe
-
DOI 10.1099/jmm.0.47738-0
-
Spigaglia P, Barbanti F, Mastrantonio P, et al. European study group on Clostridium difficile (ESGCD). fluoroquinolone resistance in Clostridium difficile isolates from a prospective study of C. difficile infections in Europe. J Med Microbiol 2008;57:784-9 (Pubitemid 351842073)
-
(2008)
Journal of Medical Microbiology
, vol.57
, Issue.6
, pp. 784-789
-
-
Spigaglia, P.1
Barbanti, F.2
Mastrantonio, P.3
Brazier, J.S.4
Barbut, F.5
Delmee, M.6
Kuijper, E.7
Poxton, I.R.8
-
9
-
-
84863676446
-
Current status of Clostridium difficile infection epidemiology
-
Lessa FC, Gould CV, McDonald LC. Current status of Clostridium difficile infection epidemiology. Clin Infect Dis 2012;55(Suppl 2):S65-70
-
(2012)
Clin Infect Dis
, vol.55
, Issue.SUPPL. 2
-
-
Lessa, F.C.1
Gould, C.V.2
McDonald, L.C.3
-
10
-
-
27444437759
-
Emergence of fluoroquinolones as the predominant risk factor for Clostridium difficile-associated diarrhea: A cohort study during an epidemic in Quebec
-
DOI 10.1086/496986
-
Pépin J, Saheb N, Coulombe MA, et al. Emergence of fluoroquinolones as the predominant risk factor for Clostridium difficile-associated diarrhea: a cohort study during an epidemic in Quebec. Clin Infect Dis 2005;41:1254-60 (Pubitemid 41532667)
-
(2005)
Clinical Infectious Diseases
, vol.41
, Issue.9
, pp. 1254-1260
-
-
Pepin, J.1
Saheb, N.2
Coulombe, M.-A.3
Alary, M.-E.4
Conriveau, M.-P.5
Authier, S.6
Leblanc, M.7
Rivard, G.8
Bettez, M.9
Primeau, V.10
Nguyen, M.11
Jacob, C.-E.12
Lanthier, L.13
-
11
-
-
80455173556
-
Host and pathogen factors for Clostridium difficile infection and colonization
-
Loo VG, Bourgault AM, Poirier L, et al. Host and pathogen factors for Clostridium difficile infection and colonization. N Engl J Med 2011;365:1693-703
-
(2011)
N Engl J Med
, vol.365
, pp. 1693-1703
-
-
Loo, V.G.1
Bourgault, A.M.2
Poirier, L.3
-
12
-
-
79958808865
-
Hepatic safety of antibiotics used in primary care
-
Andrade RJ, Tulkens PM. Hepatic safety of antibiotics used in primary care. J Antimicrob Chemother 2011;66:1431-46
-
(2011)
J Antimicrob Chemother
, vol.66
, pp. 1431-1446
-
-
Andrade, R.J.1
Tulkens, P.M.2
-
13
-
-
84867173455
-
Canadian drug safety and effectiveness research network. fluoroquinolone therapy and idiosyncratic acute liver injury: A population-based study
-
Paterson JM, Mamdani MM, Manno M, Juurlink DN. Canadian drug safety and effectiveness research network. fluoroquinolone therapy and idiosyncratic acute liver injury: a population-based study. CMAJ 2012;184:1565-70
-
(2012)
CMAJ
, vol.184
, pp. 1565-1570
-
-
Paterson, J.M.1
Mamdani, M.M.2
Manno, M.3
Juurlink, D.N.4
-
14
-
-
33645833853
-
Drug interactions during therapy with three major groups of antimicrobial agents
-
Shakeri-Nejad K, Stahlmann R. Drug interactions during therapy with three major groups of antimicrobial agents. Expert Opin Pharmacother 2006(7):639-51
-
(2006)
Expert Opin Pharmacother
, vol.7
, pp. 639-651
-
-
Shakeri-Nejad, K.1
Stahlmann, R.2
-
16
-
-
84859400803
-
Oral fluoroquinolones and the risk of retinal detachment
-
Etminan M, Forooghian F, Brophy JM, et al. Oral fluoroquinolones and the risk of retinal detachment. JAMA 2012;307:1414-19
-
(2012)
JAMA
, vol.307
, pp. 1414-1419
-
-
Etminan, M.1
Forooghian, F.2
Brophy, J.M.3
-
17
-
-
84869060547
-
Association between oral fluoroquinolones and retinal detachment
-
Albini TA, Karakousis PC, Abbey AM, et al. Association between oral fluoroquinolones and retinal detachment. Am J Ophthalmol 2012;154:919-21
-
(2012)
Am J Ophthalmol
, vol.154
, pp. 919-921
-
-
Albini, T.A.1
Karakousis, P.C.2
Abbey, A.M.3
-
18
-
-
84872278938
-
Flashes, floaters, and oral fluoroquinolones
-
Han DP, Szabo A. Flashes, floaters, and oral fluoroquinolones. Arch Ophthalmol 2013;131:91-3
-
(2013)
Arch Ophthalmol
, vol.131
, pp. 91-93
-
-
Han, D.P.1
Szabo, A.2
-
19
-
-
33845512496
-
Antimicrobial-associated QT interval prolongation: Pointes of interest
-
DOI 10.1086/508873
-
Owens RC Jr, Nolin TD. Antimicrobial-associated QT interval prolongation: pointes of interest. Clin Infect Dis 2006;43:1603-11 (Pubitemid 44910994)
-
(2006)
Clinical Infectious Diseases
, vol.43
, Issue.12
, pp. 1603-1611
-
-
Owens Jr., R.C.1
Nolin, T.D.2
-
20
-
-
83155165270
-
QT prolongation and torsade de pointes induced by fluoroquinolones: Infrequent side effects from commonly used medications
-
Briasoulis A, Agarwal V, Pierce WJ. QT prolongation and torsade de pointes induced by fluoroquinolones: infrequent side effects from commonly used medications. Cardiology 2011;120:103-10
-
(2011)
Cardiology
, vol.120
, pp. 103-110
-
-
Briasoulis, A.1
Agarwal, V.2
Pierce, W.J.3
-
21
-
-
60749101340
-
Effect of macrolide and fluoroquinolone antibacterials on the risk of ventricular arrhythmia and cardiac arrest: An observational study in Italy using case-control, case-crossover and case-time-control designs
-
Zambon A, Polo Friz H, Contiero P, Corrao G. Effect of macrolide and fluoroquinolone antibacterials on the risk of ventricular arrhythmia and cardiac arrest: an observational study in Italy using case-control, case-crossover and case-time-control designs. Drug Saf 2009;32:159-67
-
(2009)
Drug Saf
, vol.32
, pp. 159-167
-
-
Zambon, A.1
Polo Friz, H.2
Contiero, P.3
Corrao, G.4
-
22
-
-
84861076083
-
Hallet al. Azithromycin and the risk of cardiovascular death
-
Ray WA, Murray KT, Hallet al. Azithromycin and the risk of cardiovascular death. N Engl J Med 2012;366:1881-90
-
(2012)
N Engl J Med
, vol.366
, pp. 1881-1890
-
-
Ray, W.A.1
Murray, K.T.2
-
23
-
-
84874099261
-
The Effect of combination fluoroquinolone and azole use on QT prolongation in hematology patients
-
Zeuli JD, Wilson JW, Estes LL. The Effect of combination fluoroquinolone and azole use on QT prolongation in hematology patients. Antimicrob Agents Chemother 2013;57:1121-7
-
(2013)
Antimicrob Agents Chemother
, vol.57
, pp. 1121-1127
-
-
Zeuli, J.D.1
Wilson, J.W.2
Estes, L.L.3
-
24
-
-
84869026328
-
Fluoroquinolones and the risk of serious arrhythmia: A population-based study
-
Lapi F, Wilchesky M, Kezouh A, et al. Fluoroquinolones and the risk of serious arrhythmia: a population-based study. Clin Infect Dis 2012;55:1457-65
-
(2012)
Clin Infect Dis
, vol.55
, pp. 1457-1465
-
-
Lapi, F.1
Wilchesky, M.2
Kezouh, A.3
-
25
-
-
28144464151
-
A randomized trial comparing the cardiac rhythm safety of moxifloxacin vs levofloxacin in elderly patients hospitalized with community-acquired pneumonia
-
DOI 10.1378/chest.128.5.3398
-
Morganroth J, Dimarco JP, Anzueto A, et al. A randomized trial comparing the cardiac rhythm safety of moxifloxacin vs levofloxacin in elderly patients hospitalized with community-acquired pneumonia. Chest 2005;128:3398-406 (Pubitemid 41698670)
-
(2005)
Chest
, vol.128
, Issue.5
, pp. 3398-3406
-
-
Morganroth, J.1
DiMarco, J.P.2
Anzueto, A.3
Niederman, M.S.4
Choudhri, S.5
-
26
-
-
77950203711
-
Severe QT interval prolongation associated with moxifloxacin: A case report
-
Koide T, Shiba M, Tanaka K, et al. Severe QT interval prolongation associated with moxifloxacin: a case report. Cases J 2008;1:409
-
(2008)
Cases J
, vol.1
, pp. 409
-
-
Koide, T.1
Shiba, M.2
Tanaka, K.3
-
27
-
-
1542316304
-
Torsades de pointes associated with fluoroquinolones: Importance of concomitant risk factors
-
DOI 10.1016/j.clpt.2003.11.376, PII S0009923603006349
-
Amankwa K, Krishnan SC, Tisdale JE. Torsades de pointes associated with fluoroquinolones: importance of concomitant risk factors. Clin Pharmacol Ther 2004;75:242-7 (Pubitemid 38314874)
-
(2004)
Clinical Pharmacology and Therapeutics
, vol.75
, Issue.3
, pp. 242-247
-
-
Amankwa, K.1
Krishnan, S.C.2
Tisdale, J.E.3
-
28
-
-
26044471430
-
Hypoglycemia in inpatients after gatifloxacin or levofloxacin therapy: Nested case-control study
-
DOI 10.1592/phco.2005.25.10.1296
-
Graumlich JF, Habis S, Avelino RR, et al. Hypoglycemia in inpatients after gatifloxacin or levofloxacin therapy: nested case-control study. Pharmacotherapy 2005;25:1296-302 (Pubitemid 41407625)
-
(2005)
Pharmacotherapy
, vol.25
, Issue.10
, pp. 1296-1302
-
-
Graumlich, J.F.1
Habis, S.2
Avelino, R.R.3
Salverson, S.M.4
Gaddamanugu, M.5
Jamma, K.6
Aldag, J.C.7
-
29
-
-
33645399023
-
Outpatient gatifloxacin therapy and dysglycemia in older adults
-
Park-Wyllie LY, Juurlink DN, Kopp A, et al. Outpatient gatifloxacin therapy and dysglycemia in older adults. N Engl J Med 2006;354:1352-61
-
(2006)
N Engl J Med
, vol.354
, pp. 1352-1361
-
-
Park-Wyllie, L.Y.1
Juurlink, D.N.2
Kopp, A.3
-
30
-
-
67651115472
-
Severe dysglycemia with the fluoroquinolones: A class effect?
-
Aspinall SL, Good CB, Jiang R et al. Severe dysglycemia with the fluoroquinolones: a class effect? Clin Infect Dis 2009;49:402-8
-
(2009)
Clin Infect Dis
, vol.49
, pp. 402-408
-
-
Aspinall, S.L.1
Good, C.B.2
Jiang, R.3
-
31
-
-
77954886592
-
Anti-infectives and the risk of severe hypoglycemia in users of glipizide or glyburide
-
Schelleman H, Bilker WB, Brensinger CM, et al. Anti-infectives and the risk of severe hypoglycemia in users of glipizide or glyburide. Clin Pharmacol Ther 2010;88:214-22
-
(2010)
Clin Pharmacol Ther
, vol.88
, pp. 214-222
-
-
Schelleman, H.1
Bilker, W.B.2
Brensinger, C.M.3
-
32
-
-
84900348286
-
Growth inhibition of prematures receiving tetracycline
-
Cohlan SQ, Bevelander G, Tiamsic T. Growth inhibition of prematures receiving tetracycline. Am J Dis Child 1963;105:453-61
-
(1963)
Am J Dis Child
, vol.105
, pp. 453-461
-
-
Cohlan, S.Q.1
Bevelander, G.2
Tiamsic, T.3
-
34
-
-
15944373044
-
Effects on connective tissue structures
-
Hooper D, Rubinstein E, editors American Society for Microbiology, Washington;
-
Stahlmann R. Effects on connective tissue structures. In: Hooper D, Rubinstein E, editors. Quinolone antimicrobial agents. 3rd edition. American Society for Microbiology, Washington; 2003. p. 441-9
-
(2003)
Quinolone Antimicrobial Agents. 3rd Edition
, pp. 441-449
-
-
Stahlmann, R.1
-
35
-
-
60249094709
-
Quinolone-induced arthropathy: An update focusing on new mechanistic and clinical data
-
Sendzik J, Lode H, Stahlmann R. Quinolone-induced arthropathy: an update focusing on new mechanistic and clinical data. Int J Antimicrob Agents 2009;33:194-200
-
(2009)
Int J Antimicrob Agents
, vol.33
, pp. 194-200
-
-
Sendzik, J.1
Lode, H.2
Stahlmann, R.3
-
37
-
-
84879366097
-
Full prescribing information
-
October
-
Bayer. Full prescribing information, Cipro-, October 2011
-
(2011)
Cipro
-
-
Bayer1
-
38
-
-
33845404107
-
An open-label, double tympanocentesis study of levofloxacin therapy in children with, or at high risk for, recurrent or persistent acute otitis media
-
DOI 10.1097/01.inf.0000246828.13834.f9, PII 0000645420061200000003
-
Arguedas A, Dagan R, Pichichero M, et al. An open-label, double tympanocentesis study of levofloxacin therapy in children with, or at high risk for, recurrent or persistent acute otitis media. Pediatr Infect Dis J 2006;25:1102-9 (Pubitemid 44900672)
-
(2006)
Pediatric Infectious Disease Journal
, vol.25
, Issue.12
, pp. 1102-1109
-
-
Arguedas, A.1
Dagan, R.2
Pichichero, M.3
Leibovitz, E.4
Blumer, J.5
McNeeley, D.F.6
Melkote, R.7
Noel, G.J.8
-
39
-
-
34848819765
-
Comparative study of levofloxacin in the treatment of children with community-acquired pneumonia
-
DOI 10.1097/INF.0b013e3180cbd2c7, PII 0000645420071000000002
-
Bradley JS, Arguedas A, Blumer JL, et al. Comparative study of levofloxacin in the treatment of children with community-acquired pneumonia. Pediatr Infect Dis J 2007;26:868-78 (Pubitemid 47494158)
-
(2007)
Pediatric Infectious Disease Journal
, vol.26
, Issue.10
, pp. 868-878
-
-
Bradley, J.S.1
Arguedas, A.2
Blumer, J.L.3
Saez-Llorens, X.4
Melkote, R.5
Noel, G.J.6
-
40
-
-
34848893647
-
Comparative safety profile of levofloxacin in 2523 children with a focus on four specific musculoskeletal disorders
-
DOI 10.1097/INF.0b013e3180cbd382, PII 0000645420071000000003
-
Noel GJ, Bradley JS, Kauffman RE, et al. Comparative safety profile of levofloxacin in 2523 children with a focus on four specific musculoskeletal disorders. Pediatr Infect Dis J 2007;26:879-91 (Pubitemid 47494159)
-
(2007)
Pediatric Infectious Disease Journal
, vol.26
, Issue.10
, pp. 879-891
-
-
Noel, G.J.1
Bradley, J.S.2
Kauffman, R.E.3
Duffy, C.M.4
Gerbino, P.G.5
Arguedas, A.6
Bagchi, P.7
Balis, D.A.8
Blumer, J.L.9
-
41
-
-
46249118647
-
A randomized comparative study of levofloxacin versus amoxicillin/clavulanate for treatment of infants and young children with recurrent or persistent acute otitis media
-
Noel GJ, Blumer JL, Pichichero ME, et al. A randomized comparative study of levofloxacin versus amoxicillin/clavulanate for treatment of infants and young children with recurrent or persistent acute otitis media. Pediatr Infect Dis J 2008;27:483-9
-
(2008)
Pediatr Infect Dis J
, vol.27
, pp. 483-489
-
-
Noel, G.J.1
Blumer, J.L.2
Pichichero, M.E.3
-
42
-
-
34848853611
-
Will fluoroquinolones ever be recommended for common infections in children?
-
DOI 10.1097/INF.0b013e3180cc20e4, PII 0000645420071000000001
-
Schaad UB. Will fluoroquinolones ever be recommended for common infections in children? Pediatr Infect Dis J 2007;26:865-7 (Pubitemid 47494157)
-
(2007)
Pediatric Infectious Disease Journal
, vol.26
, Issue.10
, pp. 865-867
-
-
Schaad, U.B.1
-
43
-
-
23244437932
-
Safety and efficacy of gatifloxacin therapy for children with recurrent acute otitis media (AOM) and/or AOM treatment failure
-
DOI 10.1086/431584
-
Pichichero ME, Arguedas A, Dagan R, et al. Safety and efficacy of gatifloxacin therapy for children with recurrent acute otitis media (AOM) and/or AOM treatment failure. Clin Infect Dis 2005;41:470-8 (Pubitemid 41099638)
-
(2005)
Clinical Infectious Diseases
, vol.41
, Issue.4
, pp. 470-478
-
-
Pichichero, M.E.1
Arguedas, A.2
Dagan, R.3
Sher, L.4
Saez-Llorens, X.5
Hamed, K.6
Echols, R.7
-
44
-
-
78049442053
-
Two pediatric cases of multidrug-resistant tuberculosis treated with linezolid and moxifloxacin
-
Pinon M, Scolfaro C, Bignamini E, et al. Two pediatric cases of multidrug-resistant tuberculosis treated with linezolid and moxifloxacin. Pediatrics 2010;126:e1253-6
-
(2010)
Pediatrics
, vol.126
-
-
Pinon, M.1
Scolfaro, C.2
Bignamini, E.3
-
45
-
-
47349092626
-
Severe acute polyarthritis in a child after high doses of moxifloxacin
-
DOI 10.1080/00365540701849931, PII 791972582
-
Torres JR, Bajares A. Severe acute polyarthritis in a child after high doses of moxifloxacin. Scand J Infect Dis 2008;40:582-4 (Pubitemid 351997683)
-
(2008)
Scandinavian Journal of Infectious Diseases
, vol.40
, Issue.6-7
, pp. 582-584
-
-
Torres, J.R.1
Bajares, A.2
-
46
-
-
60649116473
-
Death following bilateral complete Achilles tendon rupture in a patient on fluoroquinolone therapy: A case report
-
Gottschalk AW, Bachman JW. Death following bilateral complete Achilles tendon rupture in a patient on fluoroquinolone therapy: a case report. J Med Case Rep 2009;3:1
-
(2009)
J Med Case Rep
, vol.3
, pp. 1
-
-
Gottschalk, A.W.1
Bachman, J.W.2
-
47
-
-
0034800321
-
Tendon disorders attributed to fluoroquinolones: A study on 42 spontaneous reports in the period 1988 to 1998
-
van der Linden PD, van Puijenbroek EP, Feenstra J, et al. Tendon disorders attributed to fluoroquinolones: a study on 42 spontaneous reports in the period 1988 to 1998. Arthritis Rheum 2001;45:235-9 (Pubitemid 32952902)
-
(2001)
Arthritis Care and Research
, vol.45
, Issue.3
, pp. 235-239
-
-
Van Der Linden, P.D.1
Van Puijenbroek, E.P.2
Feenstra, J.3
In T Veld, B.A.4
Sturkenboom, M.C.J.M.5
Herings, R.M.C.6
Leufkens, H.G.M.7
Ch Stricker, B.H.8
-
48
-
-
0036606890
-
Fluoroquinolones and risk of Achilles tendon disorders: Case-control study
-
van der Linden PD, Sturkenboom MC, Herings RM, et al. Fluoroquinolones and risk of Achilles tendon disorders: case-control study. BMJ 2002;324:1306-7 (Pubitemid 34606771)
-
(2002)
British Medical Journal
, vol.324
, Issue.7349
, pp. 1306-1307
-
-
Van Der Linden, P.D.1
Sturkenboom, M.C.J.M.2
Herings, R.M.C.3
Leufkens, H.G.M.4
Stricker, B.H.Ch.5
-
49
-
-
0037792114
-
Fluoroquinolone-associated tendinopathy: A critical review of the literature
-
DOI 10.1086/375078
-
Khaliq Y, Zhanel GG. Fluoroquinolone-associated tendinopathy: a critical review of the literature. Clin Infect Dis 2003;36:1404-10 (Pubitemid 36702874)
-
(2003)
Clinical Infectious Diseases
, vol.36
, Issue.11
, pp. 1404-1410
-
-
Khaliq, Y.1
Zhanel, G.G.2
-
50
-
-
84869228469
-
Impact of age, sex, obesity, and steroid use on quinolone-associated tendon disorders
-
Wise BL, Peloquin C, Choi H, et al. Impact of age, sex, obesity, and steroid use on quinolone-associated tendon disorders. Am J Med 2012;125:1228.e23-1228.e28
-
(2012)
Am J Med
, vol.125
-
-
Wise, B.L.1
Peloquin, C.2
Choi, H.3
-
51
-
-
20444412319
-
Fluoroquinolones cause changes in extracellular matrix, signalling proteins, metalloproteinases and caspase-3 in cultured human tendon cells
-
DOI 10.1016/j.tox.2005.04.002, PII S0300483X05001757
-
Sendzik J, Shakibaei M, Schäfer-Korting M, Stahlmann R. Fluoroquinolones cause changes in extracellular matrix, signalling proteins, metalloproteinases and caspase-3 in cultured human tendon cells. Toxicology 2005;212:24-36 (Pubitemid 40807461)
-
(2005)
Toxicology
, vol.212
, Issue.1
, pp. 24-36
-
-
Sendzik, J.1
Shakibaei, M.2
Schafer-Korting, M.3
Stahlmann, R.4
-
52
-
-
76749109407
-
Synergistic effects of dexamethasone and quinolones on human-derived tendon cells
-
Sendzik J, Shakibaei M, Schäfer-Korting M, et al. Synergistic effects of dexamethasone and quinolones on human-derived tendon cells. Int J Antimicrob Agents 2010;35:366-74
-
(2010)
Int J Antimicrob Agents
, vol.35
, pp. 366-374
-
-
Sendzik, J.1
Shakibaei, M.2
Schäfer-Korting, M.3
-
53
-
-
77950294897
-
Safety and tolerability of commonly prescribed oral antibiotics for the treatment of respiratory tract infections
-
Lode H. Safety and tolerability of commonly prescribed oral antibiotics for the treatment of respiratory tract infections. Am J Med 2010;123:S26-38
-
(2010)
Am J Med
, vol.123
-
-
Lode, H.1
-
54
-
-
77949366024
-
Safety considerations of fluoroquinolones in the elderly: An update
-
Stahlmann R, Lode H. Safety considerations of fluoroquinolones in the elderly: an update. Drugs Aging 2010;27:193-209
-
(2010)
Drugs Aging
, vol.27
, pp. 193-209
-
-
Stahlmann, R.1
Lode, H.2
-
55
-
-
84872184684
-
Unnecessary antimicrobial use in patients with current or recent Clostridium difficile infection
-
Shaughnessy MK, Amundson WH, Kuskowski MA, et al. Unnecessary antimicrobial use in patients with current or recent Clostridium difficile infection. Infect Control Hosp Epidemiol 2013;34:109-16
-
(2013)
Infect Control Hosp Epidemiol
, vol.34
, pp. 109-116
-
-
Shaughnessy, M.K.1
Amundson, W.H.2
Kuskowski, M.A.3
-
56
-
-
84867387020
-
Geriatric pharmacology and pharmacotherapy education for health professionals and students: A systematic review
-
Keijsers CJ, van Hensbergen L, Jacobs L, et al. Geriatric pharmacology and pharmacotherapy education for health professionals and students: a systematic review. Br J Clin Pharmacol 2012;74:762-73
-
(2012)
Br J Clin Pharmacol
, vol.74
, pp. 762-773
-
-
Keijsers, C.J.1
Van Hensbergen, L.2
Jacobs, L.3
|